EviCore, a third-party vendor, denied the request for Horizon to cover the CT scan. An NJ bill would prohibit insurers from ...

The FDA approved ensartinib (Ensacove) as a first-line treatment for adults with ALK -positive locally advanced or metastatic ...

Lung cancer is one of the most common, most dangerous, and most frequently talked about forms of cancer in the world. Of all ...

The U.S. Food and Drug Administration has declined to approve an injectable version of Johnson & Johnson's drug Rybrevant for ...

The U.S. Preventive Services Task Force recommends a low-dose CT scan of the chest for anyone who is between ages 50 and 80 ...

Woman from Central Texas thought she had allergies. Then she learned she had lung cancer, although she never smoked.

Researchers at the Icahn School of Medicine at Mount Sinai have identified the mechanism of action of a treatment for ...

Researchers say that deteriorating car tires and decomposing garbage are sending minute plastic fragments into the air, which ...

Lord Henry Mountcharles has revealed how he still struggles with living with lung cancer after the disease left him fighting ...

Fred Hutch Cancer Center’s Lonnie A. Nelson, PhD; Jason Mendoza, MD, MPH; and Myra Parker, JD, MPH, PhD, were awarded a U19 ...

An alarming trend in lung cancer diagnoses is sweeping the nation and showing up here on the Gulf Coast. It’s particularly ...

AstraZeneca Plc’s drug Tagrisso won clearance in the European Union for an advanced form of non-small cell lung cancer, extending the revenue potential for the drugmaker’s top-selling cancer medicine.